🔎 Trials Near Me

홈 › 위암 › 텍사스 › Houston

TX Houston의 위암 임상 시험

위암 관련 연구 42개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

피험자 모집 중2상
  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06760819

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

피험자 모집 중관찰 연구건강한 지원자 환영
  • UT MD Anderson Cancer Center, Houston
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

피험자 모집 중2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

피험자 모집 중2상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06219941

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

피험자 모집 중2/3상
  • University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07221149

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

피험자 모집 중3상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07700979

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

피험자 모집 중2상
  • Research Site, Houston
18세 ~ 130세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

피험자 모집 중1상
  • Baylor College of Medicine, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

피험자 모집 중1/2상
  • MD Anderson, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07705334

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

피험자 모집 중1상
  • Oncology Consultants, Houston
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

피험자 모집 중3상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

피험자 모집 중1상
  • MD Anderson Cancer Center - University of Texas, Houston
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

피험자 모집 중1상
  • UT MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06364410

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07070232

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

피험자 모집 중1/2상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07115043

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 13. 업데이트됨 · NCT07066657

A Study of MGC026 in Participants With Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • The University of Texas, MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

IDOV-Immune for Advanced Solid Tumors

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06910657

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

피험자 모집 중1/2상
  • Oncology Consultants, Houston
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT03526835

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • Investigative Site #129, Houston
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT06131840

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

피험자 모집 중2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT06695845

Lead-212 PSV359 Therapy for Patients With Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 ~ 90세 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT06710756

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

피험자 모집 중1상
  • Oncology Consultants, PA, Houston
  • Oncology Consultants, PA., Houston
  • The University of Texas M.D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center /ID# 270059, Houston
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT05005403

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT05768932

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT06789172

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06239194

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

피험자 모집 중2상
  • M D Anderson Cancer Center, Houston
18세 ~ 79세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT03161522

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06395519

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

피험자 모집 중3상
  • The University of Texas MD Anderson cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 2. 27. 업데이트됨 · NCT06532006

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

피험자 모집 중1상
  • Baylor St. Luke's Medical Center, Houston
18세 이상 · 모든 성별 · 2026. 2. 6. 업데이트됨 · NCT03740256

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

피험자 모집 중관찰 연구
  • Massive Bio SYNERGY-AI site, Houston
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT05941507

A Study of NX-1607 in Adults With Advanced Malignancies

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 9. 9. 업데이트됨 · NCT05107674

Comprehensive Outcomes for After Cancer Health

피험자 모집 중건강한 지원자 환영
  • The University of Texas MD Anderson Cancer Center, Houston
  • UT Health Houston, Houston
18세 이상 · 모든 성별 · 2024. 12. 11. 업데이트됨 · NCT05349227

다른 도시의 위암 시험

Houston의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.